Commercial Eyes
Commercial Eyes is Australia’s leading pharmaceutical and medical device commercialisation company with 22 years of experience. They deliver expertise at every stage of the therapeutic lifecycle, partnering with over 800 companies including pharmaceutical, medical device, diagnostic, and consumer healthcare firms. Their mission is to make an impact on the future of human health by transforming therapeutic innovation into market realities. They value responsiveness, diversity, collaboration, and continuous improvement, and are committed to advancing health innovation, digital health, and regulatory excellence.
Industries
Nr. of Employees
medium (51-250)
Commercial Eyes
Melbourne, Victoria, Australia, Oceania
Services
Regulatory strategy, submissions, eCTD conversion and quality system support for pharmaceuticals, medical devices and diagnostics, including preparation for regulator and client audits.
Market access strategy, health economics, HTA and evidence planning to support reimbursement, funding submissions and real-world evidence generation.
Pharmacovigilance services including risk management program design, ongoing safety monitoring, reporting and QPPV support to meet post-market obligations.
Medical information operations, enquiry handling, content governance and analytics to produce evidence-based responses and extract insights from interactions.
Design and operational delivery of patient support programs and managed access programs to improve adherence, support patient journeys and maintain regulatory compliance.
Practical advisory for companies entering the Australian market including entity consideration for marketing authorisations, distribution strategies, IP considerations and resourcing/outsourcing plans.
Regulatory strategy, submissions, eCTD conversion and quality system support for pharmaceuticals, medical devices and diagnostics, including preparation for regulator and client audits.
Market access strategy, health economics, HTA and evidence planning to support reimbursement, funding submissions and real-world evidence generation.
Pharmacovigilance services including risk management program design, ongoing safety monitoring, reporting and QPPV support to meet post-market obligations.
Medical information operations, enquiry handling, content governance and analytics to produce evidence-based responses and extract insights from interactions.
Design and operational delivery of patient support programs and managed access programs to improve adherence, support patient journeys and maintain regulatory compliance.
Practical advisory for companies entering the Australian market including entity consideration for marketing authorisations, distribution strategies, IP considerations and resourcing/outsourcing plans.
Expertise Areas
- Regulatory affairs and submissions (including eCTD)
- Pharmacovigilance and patient safety
- Market access, HTA and reimbursement strategy
- Medical information operations and analytics
Key Technologies
- eCTD (electronic Common Technical Document) and electronic dossier management
- Pharmacovigilance safety database platforms
- Cloud-based document management systems with high security controls
- Interoperability standards (FHIR, SNOMED CT)
News & Updates
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company.
TGA Certificates of Pharmaceutical Products (CPPs) support international medicine registrations, offering regulatory credibility and flexibility across global markets.
The COVID-19 pandemic accelerated digital innovation in Medical Information, redefining engagement and support for healthcare professionals.
Exploring how to leverage inboxes, calls, and reports to extract valuable insights for healthcare decision-making.
Australia’s strengths in people, partnerships, and regulation position it as a leader in pharmacovigilance across the Asia-Pacific.
Recognition for sustainability and ethical practices, achieved in 2025.
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company.
TGA Certificates of Pharmaceutical Products (CPPs) support international medicine registrations, offering regulatory credibility and flexibility across global markets.
The COVID-19 pandemic accelerated digital innovation in Medical Information, redefining engagement and support for healthcare professionals.
Exploring how to leverage inboxes, calls, and reports to extract valuable insights for healthcare decision-making.
Australia’s strengths in people, partnerships, and regulation position it as a leader in pharmacovigilance across the Asia-Pacific.
Recognition for sustainability and ethical practices, achieved in 2025.